Patents by Inventor Ting Xu

Ting Xu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230004741
    Abstract: A content aware and style aware neural network based data augmentation model generates augmented data sets to train neural network based handwriting recognition models to recognize individuals' handwriting. In embodiments, the augmented data sets are generated so as to be artificial, and to lack personal or confidential information. In embodiments, the data augmentation model generates content reference sets of individual characters generated in different fonts, and style reference sets of pluralities of characters of a particular style, for example, an individual's handwriting.
    Type: Application
    Filed: June 30, 2021
    Publication date: January 5, 2023
    Applicant: KONICA MINOLTA BUSINESS SOLUTIONS U.S.A., INC.
    Inventor: Ting XU
  • Patent number: 11529425
    Abstract: Provided is an immunoconjugate useful in inhibiting tumor growth, and a composition and/or protein mixture comprising the immunoconjugate. Also provided are methods for the production of the immunoconjugate, as well as pharmaceutical uses of the immunoconjugate in inhibiting tumor growth, including but not limited to treatment of cancers.
    Type: Grant
    Filed: September 6, 2018
    Date of Patent: December 20, 2022
    Assignee: Dingfu Biotarget Co., Ltd.
    Inventors: Ting Xu, Kai Fu, Yan Luan, Xiaojuan Liu, Jianjian Peng
  • Publication number: 20220395436
    Abstract: It relates to a cosmetic composition in the form of a transparent or semi-transparent gel, comprising (a) an oil phase; (b) a surfactant portion comprising a first non-ionic surfactant and a second non-ionic surfactant; (c) an aqueous phase; and (d) at least one C2-C6 polyol; wherein the first nonionic surfactant comprises at least one alkyl polyglucoside and the second nonionic surfactant comprises at least one having the following general formula (I) or (II): R(X)nOR? (I) wherein, R represents a linear or branched C8-C30 alkyl group or C8-C30 alkenyl group; X represents —OCH2CH2— or —OCH2—CHCH3—; n represents an integer from 2 to 100; and R? represents H, or a linear or branched C8-C30 alkyl group or C8-C30 alkenyl group; (II) wherein, the sum of x+y+z represents an integer from 2 to 100; and R1, R2, and R3, are the same or different and are each independently represents OH, or a linear or branched C8-C30 fatty acid ester group, with the proviso that at least one of R1, R2 and R3 is not OH.
    Type: Application
    Filed: September 17, 2020
    Publication date: December 15, 2022
    Inventors: Zhi Ting Jiang, Long Zhao, Yu Ting Xu, Yi Yao Wang
  • Publication number: 20220356259
    Abstract: An isolated antigen-binding protein, having one or more of the following properties: 1) capable of binding to human and monkey-derived GITR proteins at a KD value of 7×10?12 or below, wherein the KD value is measured by BLI method; 2) capable of stimulating immune cell proliferation; 3) capable of stimulating immune cells to secrete IFN-?, wherein the secretion is measured in T cell viability assay; 4) capable of inhibiting tumor growth and/or tumor cell proliferation; 5) capable of activating GITR signaling pathway; 6) capable of inhibiting the binding of GITR to GITRL.
    Type: Application
    Filed: July 16, 2020
    Publication date: November 10, 2022
    Inventors: Xin ZHANG, Ting XU, Hui MA, Yangyang YUAN, Shanshan NING, Shilong FU, Xiaolong PAN, Liyao ZHOU, Meng ZHAO, Erxia SHI
  • Publication number: 20220340731
    Abstract: Nanoscopic dispersion of trace enzymes and random heteropolymers in plastics provides to fully functional plastics with eco-friendly microplastic elimination and programmable degradation.
    Type: Application
    Filed: June 19, 2022
    Publication date: October 27, 2022
    Applicant: The Regents of the University of California
    Inventors: Ting Xu, Christopher DelRe, Junpyo Kwon
  • Publication number: 20220325000
    Abstract: Disclosed is a monoclonal antibody or an antigen binding fragment thereof which targets tissue factor pathway inhibitor (TFPI), and a medical use thereof.
    Type: Application
    Filed: August 28, 2020
    Publication date: October 13, 2022
    Applicant: Suzhou Alphamab Co., Ltd.
    Inventors: Ting Xu, Xiaoxiao Wang, Ying Fan, Yanrong Dong, Liping Chen, Jianyun Ji
  • Publication number: 20220251207
    Abstract: Disclosed are a method for treating a tumor using a CTLA4-binding protein and a use thereof, wherein the CTLA4-binding protein specifically binds to CTLA4 and does not compete with a ligand of CTLA4 for binding to CTLA4. The CTLA4-binding protein described in the present application can effectively inhibit tumor growth.
    Type: Application
    Filed: July 3, 2020
    Publication date: August 11, 2022
    Applicant: JIANGSU ALPHAMAB BIOPHARMACEUTICALS CO., LTD.
    Inventors: Ting Xu, Kangping Guo, Xiaoxiao Wang, Pilin Wang, Yuhao Jin, Qian Li
  • Publication number: 20220245789
    Abstract: Provided is a dual-neighborhood wear angle automatic detection method, including constructing a proximal neighborhood and establishing grayscale differences between a pixel in a center area and pixels having first directions in the proximal neighborhood; calculating, based on the grayscale differences, deviation degrees of all pixels in the center area in the first directions; calculating a similar direction value based on the deviation degrees; constructing a distal neighborhood and focus pixels having second directions in the distal neighborhood; calculating grayscale differences between the pixel and the focus pixels; calculating deviation degrees of all pixels in the center area, in the second directions based on the grayscale differences between the pixel and the focus pixels; calculating a direction value of a wear angle based on the deviation degrees in the second directions; and calculating the wear angle based on the direction value of the wear angle.
    Type: Application
    Filed: April 22, 2022
    Publication date: August 4, 2022
    Applicant: CHANG'AN UNIVERSITY
    Inventors: Mei XIAO, Lei ZHANG, Bing YANG, Kairui DU, Ting XU
  • Patent number: 11396557
    Abstract: The present application provides a bispecific antibody or an antibody mixture with common light chains and a preparation method therefor. the present application also provides a nucleic acid molecule encoding the antibody or the mixture, a recombinant vector and a recombinant cell comprising the nucleic acid molecule, as well as a detection and quantitation method for the antibody or the mixture.
    Type: Grant
    Filed: September 16, 2020
    Date of Patent: July 26, 2022
    Assignee: Jiangsu Alphamab Biopharmaceuticals Co., Ltd.
    Inventors: Ting Xu, Tao Xu, Xiaoxiao Wang, Qian Li, Minjie Pang, Huimin Zhang, Li Han, Qingqing Zhang
  • Publication number: 20220227827
    Abstract: Proteinaceous heterodimers, pharmaceutical compositions, medicaments and/or kits comprising the proteinaceous heterodimers, methods for producing the proteinaceous heterodimers, and uses thereof.
    Type: Application
    Filed: March 24, 2020
    Publication date: July 21, 2022
    Applicant: DINGFU BIOTARGET CO., LTD.
    Inventors: Ting XU, Jianjian PENG, Kai FU, Shilong FU, Xiaolong PAN, Jian DING, Shanshan NING, Liyao ZHOU
  • Patent number: 11377497
    Abstract: The present invention relates to the field of medical biology, and discloses a high-resolution crystal structure of a complex of PD-L1-blocking heavy-chain single-domain antibody KN035 binding with PD-L1, and the use of the crystal structure. The invention also relates to novel PD-L1 binding polypeptides or compounds developed based on the crystal structure and uses thereof.
    Type: Grant
    Filed: January 23, 2018
    Date of Patent: July 5, 2022
    Assignee: SUZHOU ALPHAMAB CO., LTD.
    Inventors: Ting Xu, Aiwu Zhou, Yuhao Jin, Ling Wang, Jie Wu, Hongqin Hu, Xiaoxiao Wang
  • Patent number: 11357826
    Abstract: The present disclosure provides proteinaceous complexes, pharmaceutical compositions, medicaments and/or kits comprising the proteinaceous complexes, methods for producing the proteinaceous complexes, and uses thereof.
    Type: Grant
    Filed: August 21, 2019
    Date of Patent: June 14, 2022
    Assignee: DINGFU BIOTARGET CO., LTD.
    Inventors: Ting Xu, Yan Luan, Jianjian Peng, Shuli Ma, Meng Zhao, Xiaoxiao Wang, Hui Ma, Shilong Fu, Xiaolong Pan, Shanshan Ning
  • Publication number: 20220177588
    Abstract: The present invention relates to the field of medical biology, and discloses a single domain antibody and derivative proteins thereof against CTLA4. In particular, the present invention discloses a CTLA4 binding protein and the use thereof, especially the use for treating and/or preventing CTLA4 relevant diseases such as tumor.
    Type: Application
    Filed: July 7, 2021
    Publication date: June 9, 2022
    Inventors: Ting Xu, Xiaoxiao Wang, Jie Li, Haiyan Wu, Li Gao, Qian Chu, Yu Bai
  • Patent number: 11295155
    Abstract: A method and system to generate training data for a deep learning model in memory instead of loading pre-generated data from disk storage. A corpus may be stored as lines of text. The lines of text can be manipulated in the memory of a central processing unit (CPU) of a computing system, using asynchronous multi-processing, in parallel with a training process being conducted on the system's graphics processing unit (GPU). With such an approach, for a given line of text, it is possible to take advantage of different fonts and different types of image augmentation without having to put the images in disk storage for subsequent retrieval. Consequently, the same line of text can be used to generate different training images for use in different epochs, providing more variability in training data (no training sample is trained on more than once). A single training corpus may yield many different training data sets.
    Type: Grant
    Filed: April 8, 2020
    Date of Patent: April 5, 2022
    Assignee: KONICA MINOLTA BUSINESS SOLUTIONS U.S.A., INC.
    Inventor: Ting Xu
  • Patent number: 11246296
    Abstract: Aspects of the present disclosure relate to a bird bath. In one configuration, a frame as a plurality lighting elements therein. A stand is provided for supporting the frame. The bath may include a control component for controlling the lighting elements and a photovoltaic cell for providing power to the lighting elements. In another aspect, the frame may include a plurality of spiral frame members. In yet another aspect, the spiral members have a channel pathway and the lighting elements are disposed in the channel pathway. In yet another aspect, the frame may includes a plurality of radial members. In yet another aspect, the radial members have a channel pathway and the lighting elements are disposed in the channel pathway.
    Type: Grant
    Filed: July 2, 2019
    Date of Patent: February 15, 2022
    Assignee: Evergreen Enterprises of Virginia, LLC
    Inventors: Ting Xu, Kristina Sarullo, Jordan Cai
  • Patent number: D955371
    Type: Grant
    Filed: June 27, 2019
    Date of Patent: June 21, 2022
    Assignee: HUAWEI TECHNOLOGIES CO., LTD.
    Inventors: Joon Suh Kim, Ting Xu, Zhenqi Tang, Lu Huang
  • Patent number: D959397
    Type: Grant
    Filed: February 14, 2020
    Date of Patent: August 2, 2022
    Assignee: HUAWEI TECHNOLOGIES CO., LTD.
    Inventors: Ting Xu, Jie Huang, Guang Cao, Mengyao Xie, Fei Wang
  • Patent number: D965710
    Type: Grant
    Filed: September 10, 2021
    Date of Patent: October 4, 2022
    Inventor: Ting Xu
  • Patent number: D967802
    Type: Grant
    Filed: September 28, 2020
    Date of Patent: October 25, 2022
    Inventors: Qingsen Zhang, Junling Chen, Ting Xu
  • Patent number: D974344
    Type: Grant
    Filed: March 26, 2021
    Date of Patent: January 3, 2023
    Assignee: HUAWEI TECHNOLOGIES CO., LTD.
    Inventors: Joon Suh Kim, Ting Xu, Guoping Wu, Jiaxi Wang, Jue Yuan